首页> 外国专利> VASCULAR ENDOTHELIAL CELL GROWTH FACTOR INHIBITOR AND ANTICANCER AGENT CONTAINING THE SAME, AND COX-2 INHIBITOR AND ANTI-INFLAMMATORY AGENT AND ANTICANCER AGENT CONTAINING THE SAME.

VASCULAR ENDOTHELIAL CELL GROWTH FACTOR INHIBITOR AND ANTICANCER AGENT CONTAINING THE SAME, AND COX-2 INHIBITOR AND ANTI-INFLAMMATORY AGENT AND ANTICANCER AGENT CONTAINING THE SAME.

机译:包含相同成分的血管内皮细胞生长因子抑制剂和抗癌剂,以及包含相同成分的COX-2抑制剂和抗炎剂和抗癌剂。

摘要

PROBLEM TO BE SOLVED: To provide a new VEGF inhibitor and an anticancer agent containing the same as an active ingredient, and a new selective COX-2 inhibitor and an anti-inflammatory agent and anticancer agent containing the same as an active ingredient.;SOLUTION: This VEGF inhibitor is expressed by general formula (1) [wherein, R1, R2 are each phenyl, a heterocyclic group, or the phenyl or heterocyclic group of which at least one H is substituted by a group selected from a group consisting of hydroxy, a 1-10C alkyl, a 1-10C alkoxy and R3-S- group (wherein, R3 is a 1-10C alkyl) or a halogen atom, and R1, R2 are each the same or different]. The anticancer agent contains the VEGF inhibitor as the active ingredient. The anti-inflammatory agent and anticancer agent contain the new selective COX-2 inhibitor as the active ingredient.;COPYRIGHT: (C)2004,JPO
机译:解决的问题:提供一种新的VEGF抑制剂和一种含有该抑制剂作为有效成分的抗癌剂,以及一种新的选择性COX-2抑制剂和一种含有该抑制剂作为有效成分的抗炎剂和抗癌剂。 :该VEGF抑制剂由通式(1)表示。[式中,R 1 ,R 2 分别为苯基,杂环基或苯基或杂环基。至少一个H被选自羟基,1-10C烷基,1-10C烷氧基和R 3 -S-基团的基团取代(其中,R 3 是1-10C烷基)或卤原子,R 1 ,R 2 相同或不同]。该抗癌剂含有VEGF抑制剂作为活性成分。该消炎剂和抗癌剂含有新型的选择性COX-2抑制剂作为有效成分。;版权所有:(C)2004,日本特许厅

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号